TEAS RF New Application

LIVIMMUNE

CytoDyn Inc.

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88751607
Filing Date: 01/08/2020

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88751607
MARK INFORMATION
*MARK LIVIMMUNE
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT LIVIMMUNE
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK CytoDyn Inc.
INTERNAL ADDRESS Suite 660
*STREET 1111 Main Street
*CITY Vancouver
*STATE
(Required for U.S. applicants)
Washington
*COUNTRY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
98660
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Therapeutic preparations; therapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor; therapeutic preparations for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 042 
*IDENTIFICATION Scientific research consulting services; scientific research consulting services in the field of antibodies for use in targeting the CCR5 cell receptor; scientific research consulting services in the field of therapeutic agents, preparations and substances for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis; medical research and analysis services; medical research and analysis services in the field of antibodies for use in targeting the CCR5 cell receptor; medical research and analysis services in the field of therapeutic agents, preparations and substances for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 044 
*IDENTIFICATION Providing health and medical information; providing a website featuring health and medical information; providing a website featuring information in the field of antibodies for use in targeting the CCR5 cell receptor; providing a website featuring information in the field of therapeutic agents, preparations and substances for treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Jared M. Barrett
ATTORNEY DOCKET NUMBER 230042.205
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Seed IP Law Group LLP
STREET 701 Fifth Avenue, Suite 5400
CITY Seattle
STATE Washington
COUNTRY United States
ZIP/POSTAL CODE 98104
PHONE 206-622-4900
EMAIL ADDRESS USTM.DOCKETING@SEEDIP.COM
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
OTHER APPOINTED ATTORNEY E. Russell Tarleton, Kevin S. Costanza, Hayley J. Talbert, Syed Abedi, Duncan Stark, Russell C. Pangborn, Marc C. Levy, Brooke W. Quist, Kevan L. Morgan, Stephen J. Rosenman, Bradley Zentz, Brigid C. Mahoney , David Chen, and Thomas A. Shewmake
CORRESPONDENCE INFORMATION
NAME Jared M. Barrett
FIRM NAME Seed IP Law Group LLP
STREET 701 Fifth Avenue, Suite 5400
CITY Seattle
STATE Washington
COUNTRY United States
ZIP/POSTAL CODE 98104
PHONE 206-622-4900
*EMAIL ADDRESS USTM.DOCKETING@SEEDIP.COM
*AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
FEE INFORMATION
APPLICATION FILING OPTION TEAS RF
NUMBER OF CLASSES 3
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEE DUE 825
*TOTAL FEE PAID 825
SIGNATURE INFORMATION
SIGNATURE /Jared M. Barrett/
SIGNATORY'S NAME Jared M. Barrett
SIGNATORY'S POSITION Attorney for Applicant, Washington State Bar Member
SIGNATORY'S PHONE NUMBER 206-622-4900
DATE SIGNED 01/08/2020



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 88751607
Filing Date: 01/08/2020

To the Commissioner for Trademarks:

MARK: LIVIMMUNE (Standard Characters, see mark)
The literal element of the mark consists of LIVIMMUNE. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, CytoDyn Inc., a corporation of Delaware, having an address of
      Suite 660
      1111 Main Street
      Vancouver, Washington 98660
      United States

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Therapeutic preparations; therapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor; therapeutic preparations for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 042:  Scientific research consulting services; scientific research consulting services in the field of antibodies for use in targeting the CCR5 cell receptor; scientific research consulting services in the field of therapeutic agents, preparations and substances for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis; medical research and analysis services; medical research and analysis services in the field of antibodies for use in targeting the CCR5 cell receptor; medical research and analysis services in the field of therapeutic agents, preparations and substances for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 044:  Providing health and medical information; providing a website featuring health and medical information; providing a website featuring information in the field of antibodies for use in targeting the CCR5 cell receptor; providing a website featuring information in the field of therapeutic agents, preparations and substances for treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The applicant hereby appoints Jared M. Barrett. Other appointed attorneys are E. Russell Tarleton, Kevin S. Costanza, Hayley J. Talbert, Syed Abedi, Duncan Stark, Russell C. Pangborn, Marc C. Levy, Brooke W. Quist, Kevan L. Morgan, Stephen J. Rosenman, Bradley Zentz, Brigid C. Mahoney , David Chen, and Thomas A. Shewmake. Jared M. Barrett of Seed IP Law Group LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      701 Fifth Avenue, Suite 5400
      Seattle, Washington 98104
      United States
      206-622-4900(phone)
      USTM.DOCKETING@SEEDIP.COM (authorized).
The attorney docket/reference number is 230042.205.
Jared M. Barrett submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      Jared M. Barrett
      Seed IP Law Group LLP
      701 Fifth Avenue, Suite 5400
      Seattle, Washington 98104
      206-622-4900(phone)
      USTM.DOCKETING@SEEDIP.COM (authorized).

Email Authorization: I authorize the USPTO to send email correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the email address provided in this application. I understand that a valid email address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $825 has been submitted with the application, representing payment for 3 class(es).

Declaration

Declaration Signature

Signature: /Jared M. Barrett/   Date: 01/08/2020
Signatory's Name: Jared M. Barrett
Signatory's Position: Attorney for Applicant, Washington State Bar Member
Payment Sale Number: 88751607
Payment Accounting Date: 01/08/2020

Serial Number: 88751607
Internet Transmission Date: Wed Jan 08 17:30:54 EST 2020
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.XXX-202001081730546
79497-88751607-700f42a22914fffd2321427b2
d691a3afe3c11b6d59a6547315ea154491ef729-
CC-30530901-20200108171005868286

TEAS RF New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed